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Abstract: Lycopene is a desired ingredient in food formulations, yet its beneficial effects on
human health remain largely underexploited due to its poor chemical stability and bioavailability.
Oil-in-water emulsions may offer multiple advantages for the incorporation and delivery of this
carotenoid species. Engineering and processing aspects for the development of emulsion-based
delivery systems are of paramount importance for maintaining the structural integrity of lycopene.
The selection of emulsifiers, pH, temperature, oil phase, particle size, homogenization conditions
and presence of other antioxidants are major determinants for enhancing lycopene stability and
delivery from a food emulsion. Process and formulation optimization of the delivery system is
product-specific and should be tailored accordingly. Further research is required to better understand
the underlying mechanisms of lycopene absorption by the human digestive system.
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1. Introduction
Lycopene was isolated for the first time by Hartsen (1873) from Tamus communis L. berries, and a
few years later, Schunk (1903) gave its former name after showing that this pigment from tomato
had a different absorption spectrum than carotenes from carrots [1]. Although, from a nutritional
perspective, lycopene is not essential for life, it belongs to a group of compounds of immense biological
importance known as phytochemicals. Phytochemicals have attracted much attention recently due
to their documented effects on human health. Many epidemiological studies propose an inverse
relationship between the consumption of lycopene and the development of chronic diseases [2].
Lycopene’s main effect on human health is mediated through its strong antioxidant properties, which
are demonstrated in a host of chemical reactions known to be implicated in carcinogenesis and
atherogenesis [3].
The bioavailability of lycopene is a complex issue and depends on multiple factors. Firstly,
lycopene due to its highly unsaturated hydrocarbon structure is susceptible to degradation via
autooxidation or trans-cis isomerisation reactions [4]. The rate and extent of these degradation
phenomena are dependent on many environmental factors, with the most important being temperature,
light and oxygen [5]. In addition to processing and storage effects, lycopene’s bioavailability is also
limited because of its hydrophobic nature. In aqueous environments, lycopene tends to aggregate
and forms crystals, which partly explains the low levels of this carotenoid detected in serum after
a lycopene-rich meal [6]. This matrix effect may be ameliorated if lycopene is co-ingested with an
oil-based food. Finally, other host-related factors such as genetic factors are considered important for
the absorption of lycopene by the human digestive system, although these are still poorly understood.
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With increasing awareness of lycopene’s beneficial effects on the prevention of chronic diseases,
the food industry is keen on including this compound as functional ingredient in various formulations,
including beverages. However, its incorporation in food products remains problematic due to its
poor physical and chemical stability, usually derived from common processing and storage methods.
Oil-in-water emulsions are considered effective carrier systems for the delivery of lipophilic bioactive
ingredients [7]. Emulsion-based food systems confer protection against oxidation and chemical
degradation of hydrophobic compounds, thus prolonging shelf-life and potentially also enhancing the
bioaccessibility of the bioactive ingredient. The formulation and processing steps to develop such a
delivery system are critical for the physicochemical properties of the product, which in turn affects its
effectiveness as a delivery matrix.
The effects of food processing and storage on lycopene have been previously reviewed [3].
Although considerable research has been published on lycopene-containing emulsions and their
properties, a review on this topic is currently lacking from the literature. This review aims to summarize
and critically discuss the main findings related to emulsion design and processing with special focus on
lycopene stability and bioaccessibility. Optimum formulations and processing conditions are presented
for applications of lycopene as a functional ingredient in the food and drink industry.
2. Lycopene as Functional Ingredient: Structure, Properties and Health Effects
Lycopene is a natural pigment responsible for the red color of some fruits, such as tomato,
watermelon, grapefruit, guava and papaya [8,9]. It belongs to the carotenoid family; specifically,
to the class of carotenes, since it contains only carbon and hydrogen atoms. Lycopene is an
aliphatic hydrocarbon and is characterized by a symmetric structure containing 11 conjugated and 2
non-conjugated double bonds arranged in a linear array, thus making it longer than other carotenoids.
Due to its symmetrical planarity and the absence of a terminal beta ionone ring, it lacks pro-vitamin A
activity [10,11].
In nature, lycopene is mostly present in all-trans forms; however, isomerization to cis can occur in
the presence of light, exposure to heat or by chemical reactions (for example during food processing
or cooking) [12]. Theoretically, lycopene can exist in 2048 geometrical configurations, but only
72 cis-isomers of lycopene are structurally favorable (Figure 1). Cis-configuration is the most stable
thermodynamically and best absorbed by humans, with 50% of the total lycopene in human plasma
occurring as cis-lycopene. It has been hypothesized that cis-isomers are more bioavailable than all
trans-lycopene because they are more rapidly taken up by bile acids micelles and consequently their
absorption is facilitated. Moreover, cis-isomers are more soluble in lipophilic solutions and less prone
to crystallization [10,13].
Among the carotenoids, lycopene is predominant in human plasma. It has been detected at a
concentration range between 0.4 µM in North and Central Europe and up to 1.3 µM in South Italy,
hence lycopene levels are strongly related to dietary preferences [14]. Despite a significant gap of
knowledge related to lycopene absorption and metabolism in human tissue, it has been demonstrated
that lycopene accumulates unevenly in various tissues (liver, prostate gland, adipose, skin, lungs,
and colon) and its concentration tends to always be higher than those of all other carotenoids. Its
half-life in the human body varies from 2 to 33 days and depends on the levels of oxidative stress
encountered [15,16].
As humans are unable to synthesize lycopene, the diet is the only source of this component in
blood and tissues. In contrast with other carotenoids, lycopene is available mainly from a limited list
of foods. The major sources of lycopene in the western diet are tomato products; at least 85% of our
dietary lycopene comes from both tomato fruits and tomato-based products like ketchup, juice and
sauce [17,18].
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respect, mice that had been fed an atherogenic diet containing 20% (w/w) lyophilized tomato powder 
showed reduced lipid peroxide levels in plasma compared to controls, while acetylcholine-induced 
vaso-relaxation was maintained at the normal levels [25]. Moreover, human intervention studies 
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improve endothelial function and induce a significant reduction in oxidized LDL levels [26,27]. These 
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endometrial, mammary and lung human cancer cell proliferation, and a suppressor of insulin-like 
growth factor-I [34]. A significant number of studies have demonstrated that a high lycopene intake 
was inversely related to the risk of prostate, bladder and breast cancer [35,36].  
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In recent years, there is increasing awareness of the beneficial effects associated with the
consumption of lycopene-rich foods. Several studies have demonstrated that lycopene has a positive
impact on human health due to its diverse biological properties. Firstly, it is a potent antioxidant,
and has the most efficient singlet oxygen quenching capacity of the natural carotenoids (ten times more
active than α-tocopherol) [19,20]. The ability of lycopene to protect cells against oxidative damage is
thought to be responsible for decreasing the risk of chronic diseases, including cardiovascular disease.
By using different in vitro models (ECV304 endothelial cells, HUVECs, human macrophages) it has
been demonstrated that lycopene is a potential antiatherogenic agent able to prevent oxidative stress
and apoptosis. The hypothesized mechanism of action for lycopene in reducing the risk of coronary
heart disease is mediated by preventing the oxidation of low-density lipoprotein (LDL) [21–23].
This assumption is supported by epidemiological data [24], but also by in vivo studies. In this
respect, mice that had been fed an atherogenic diet containing 20% (w/w) lyophilized tomato powder
showed reduced lipid peroxide levels in plasma compared to controls, while acetylcholine-induced
vaso-relaxation was maintained at the normal levels [25]. Moreover, human intervention studies
showed that daily consumption of lycopene-rich food products (tomato sauce or paste) could
improve endothelial function and induce a significant reduction in oxidized LDL levels [26,27]. These
results indicate that lycopene has a preventive effect on atherosclerosis by protecting plasma lipids
from oxidation.
In addition to its antioxidant properties, lycopene may be further advantageous for human
health by other biochemical mechanisms. It has been shown that lycopene can induce cell to
cell communication; specifically, it stimulates gap junctional communication (GJC). Furthermore,
lycopene enhances the expression of connexin 43, a gene encoding for a major gap junction protein,
and thereby upregulates GJC [28]. Given that upregulation of GJC is correlated with growth inhibition
of precancerous cells, lycopene could also act as anticarcinogen [29,30]. Research findings showing an
inverse relationship between cancer and lycopene are based on epidemiological [31], cell culture [2] and
animal studies [32,33]. Specifically, lycopene was shown to be an inhibitor of endometrial, mammary
and lung human cancer cell proliferation, and a suppressor of insulin-like growth factor-I [34].
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A significant number of studies have demonstrated that a high lycopene intake was inversely related
to the risk of prostate, bladder and breast cancer [35,36].
Although most of the research has focused on the protective effect of lycopene on cardiovascular
and tumor diseases, it has recently been suggested that it could have other health implications. For
instance, lycopene may provide protection against cell damage induced by ionizing radiation and
therefore its supplementation could be used in mitigating the effects of a possible radiation accident,
or in diminishing the negative impact of cancer radiotherapy [37–39].
3. Stability of Lycopene in Emulsions: Formulation and Processing Implications
Lycopene is susceptible to thermal and oxidative degradation during processing and storage.
This is due to the fact that it is lipid-soluble and has a highly unsaturated structure. One way of
protecting lycopene from degradation, while at the same time improving its bioavailability, is to
incorporate it into the oil-phase of oil-in-water emulsions [40]. Although emulsions are effective
systems for functional foods, both chemical and physical stability of lycopene in emulsion delivery
systems may be problematic. Several studies have been carried out in this area, in order to understand
the most important factors influencing the stability of lycopene in emulsion-based systems. Chemical
degradation is significantly affected by a number of parameters; however, the most relevant are heat,
oxygen and light. Different studies suggest that even if thermal processing increases the amount of
cis-lycopene (by enhancing its isomerization), application of heat always decreases the content of total
lycopene present in food. Moreover, the percentage of loss depends on the method of heating (drying,
microwave, or baking) [11,16].
One of the first papers using oil-in-water emulsions for lycopene encapsulation was published by
Ax and colleagues. They investigated the stability of lycopene under oxygen saturation or oxygen-free
conditions. The results showed that higher temperatures were significantly and directly correlated
to increasing lycopene losses, regardless of the exposure to oxygen. Interestingly, in the presence of
oxygen, lycopene destabilization was about three times higher than under inert conditions. Therefore,
total lycopene degradation could be reduced by flushing the emulsion with nitrogen gas [41]. In 2003,
Ribeiro et al. confirmed the great influence of oxygen on lycopene degradation. However, they found
that lycopene degradation was accelerated when oxygen was removed by flushing the system with
nitrogen. Instead, using the enzyme glucose oxidase to completely exclude oxygen, led to a better
stability [42]. An additional aspect highlighted by this research was that the chemical stability of
lycopene strongly depends on the food systems, and emulsifiers may only have a minor impact,
depending on the food systems in which they are applied. An emulsifier is an amphiphilic molecule
that, during the emulsification process, facilitates the formation of smaller particles droplets, reduces
the interfacial tension between the oil and the water phase, and prevents droplet coalescence by
keeping the two phases mixed and stable [43]. The study by Ribeiro revealed that during storage,
emulsifiers have a limited effect on the degradation of lycopene in water compared with orange
juice and skimmed milk. Thus, in these experiments, the food systems play a more important role in
lycopene stability than the investigated emulsifiers [42].
Given the relevance of emulsifiers in emulsion delivery systems, further studies have investigated
their effect on lycopene stability in detail. In 2008, Boon et al. discovered that the formation of
lipid hydroperoxides did not vary significantly among lycopene emulsions stabilized with different
types of emulsifiers. Nevertheless, the emulsions stabilized with sodium dodecyl sulphate (SDS)
showed a faster formation of hexanal, compared to others stabilized with dodecyltrimethylammonium
bromide (DTAB) or lauryl ether (Brij 35). Hence, the great impact of the emulsion interfacial properties
on lycopene oxidation and degradation was demonstrated. As negatively charged interfaces of
emulsions droplets (SDS) were correlated with the fastest oxidation rates, the authors assumed
that cationic transition metals could be promoting lycopene degradation. A likely mechanism is
that cations may interact more rapidly with lycopene located in the droplet interior as they are
strongly attracted to the emulsion surface [44]. In a later study by Nishino et al., the photostability
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of lycopene dispersions containing gum arabic, gum ghatti and polyglycerol monostearate ester was
compared. Their results showed that the stability of lycopene in aqueous solution was influenced by
the type and amount of emulsifier used. Specifically, the most stable was the one with polyglycerol
monostearate ester, probably because when it is present at high concentrations, it forms a multilayered,
emulsifier-adsorbing layer at the interface that prevents the contact between lycopene and dissolved
oxygen [45]. More recently, Shariffa et al. investigated the specific effect of four different emulsifiers:
Tween 80, lecithin, sodium caseinate and gum arabic. They demonstrated that the emulsifier type
significantly affects the physicochemical properties of the emulsions and is one of the most important
factors to consider when producing a lycopene nanodispersion. It was shown that the size of lycopene
droplets depends on the structure and the size of the emulsifier used. Comparing the four emulsifiers,
the most stable systems were those with lecithin, having the smallest droplet size and the narrowest
particle size distribution. On the other hand, sodium caseinate was the most effective emulsifier
against lycopene degradation. Thus, despite its large size, sodium caseinate can be used to produce
stable nano-emulsions with lycopene droplets having mean diameter less than 200 nm. Instead, Tween
80 and gum arabic, were less capable to confer stability against lycopene degradation and droplet
aggregation. Therefore, an emulsion-based system with the smallest particle size is not always the
most stable, especially in the case of lycopene [46]. This finding has been confirmed by a recent
paper that studied the physicochemical stability of lycopene-loaded emulsions stabilized by plant
or dairy proteins. Once again, the capacity of sodium caseinate to stabilize an emulsion system was
demonstrated. Both sodium caseinate and pea protein-stabilized emulsions were promising delivery
vehicles, because they exhibited high chemical and physical stability after 14 days of storage [47].
Another factor that determines the stability of lycopene-emulsions is the type of oil used for
emulsion formation. As demonstrated in the study by Boon et al., lycopene degradation was varied by
using different oil carriers, and was in the order of stripped corn oil > hexadecane > corn oil. The fact
that lycopene degraded faster in the stripped corn oil and hexadecane compared to corn oil implies that
the antioxidants naturally present in corn oil (such as tocopherols), could play a protective role. It has
been hypothesized that tocopherols may inhibit lycopene oxidation because they are oxidized prior to
lycopene [44]. This theory is consistent with the findings reported previously by Ribeiro et al., which
demonstrated that the stability of lycopene in dilute emulsions was improved when α-tocopherol was
incorporated in the oil phase, by inhibiting lycopene’s degradation [42].
A significant body of literature investigated the formulation aspects of lycopene emulsions
and assessed whether these could impact on its stability, in order to identify optimum recipes for
manufacturing lycopene-loaded emulsion. Recently, two different formulations have been proposed
considering several factors, including processing type (homogenization vs. evaporation), concentration
of lycopene, type and quantity of emulsifiers and the amount of the oil-phase. According to Kim et al.
The lycopene emulsion showing the highest stability was the one obtained after three homogenization
cycles with 0.085 mg/mL of lycopene extract and 0.7 mg/mL of Tween80 [48]. On the other hand,
Shi et al. proposed an optimized microemulsion containing 0.2 g/100 g (w/w) whey protein concentrate
(WPC), 0.5 g/100 g (w/w) high-methylester-pectin (HMP) and 5 mL/100 mL oil phase fraction. This
optimized lycopene-microemulsion was more stable to thermal treatment and changes of pH, but was
particularly sensitive to NaCl treatment [49].
In conclusion, it is evident that several parameters must be considered for the fabrication of
lycopene emulsion-systems. Depending on the food application, it is important to take into account the
synergistic effects of these factors, in order to identify the optimum conditions for enhanced chemical
and physical stability of lycopene in an emulsion delivery system.
4. Factors Affecting Bioaccessibility of Lycopene in Emulsions
To exert a health benefit, lycopene needs to be bioavailable. This means that the bioactive
compound must be absorbed in the human digestive tract, undergo metabolism, and become available
in an active form at the site of action. Bioavailability of nutrients and non-nutrients depends on
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bioaccessibility. The term is used to describe the fraction of a compound that is released from the
food matrix during digestion and is thereby made available for intestinal absorption (Figure 2) [50].
Bioaccessibility depends on numerous factors, such as the composition of the digested food matrix,
the synergisms and antagonisms of the different food components, but also on physicochemical
properties, such as pH, temperature and texture of the matrix [51].
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of polyunsaturated fatty acids (PUFA). Firstly, PUFAs are susceptible to oxidation reactions and may
promote oxidation of lycopene in the intestinal chime. Secondly, the size of mixed micelles containing
PUFAs may be larger, which in turn can slow down their diffusion through the unstirred water layer
adjacent to the enterocyte and reduces their uptake at the intestinal level [59].
5. Conclusions and Future Trends
The inclusion of lycopene in food formulations is desirable, since epidemiological studies suggest
a beneficial role in chronic disease prevention. Its utilization as a functional ingredient is hindered by
the lack of chemical stability and poor absorption at the digestive tract. Current research indicates
that lycopene stability largely depends on the food system, and that processing may increase its
bioavailability. The fabrication of emulsions for delivering lycopene could be a promising option for
the food and beverage industry. However, the engineering aspects need to be carefully designed for
optimum performance. The selection of specific emulsifiers at the droplet interface and the presence
of tocopherols improves lycopene stability in oil-in-water emulsions. Additionally, droplet size and
the type of oil used for emulsion formation may be critical for absorption. There seems to be a gap in
our knowledge of lycopene absorption and metabolism from complex food systems due to the limited
number of human studies and the lack of accessible biomarkers. This results in discrepancies between
data and limited understanding of the intracellular mechanisms involved in the potent health benefits
of this carotenoid species.
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